BioMar Group
kr 122.10Change from previous close: −0.33%Absolute change: −kr 0.40
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- kr 12.24B
- Enterprise value
- kr 15.41B
- P/E (trailing 12 months)
- 17.4
- Forward P/E
- 12.2
- Price/book
- 4.38
- Price/sales
- 0.73
- EV/EBITDA
- 8.85
- EV/revenue
- 0.92
Profitability and growth
- Gross margin
- 22.3%
- Operating margin
- 14.4%
- Net margin
- 4.2%
- Revenue growth (year over year)
- 67.6%
- Earnings growth (year over year)
- -3.2%
Financial health
- Total cash
- kr 563M
- Total debt
- kr 3.74B
- Debt/equity
- 1.34
- Current ratio
- 1.07
- Quick ratio
- 0.65
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- kr 141.00
- Median price target
- kr 140.00
- High price target
- kr 155.00
- Low price target
- kr 126.00
- Analysts with a price target
- 5
- Consensus
- Buy
- Forward EPS
- kr 10.02
- EPS estimate, current year
- kr 8.81
Shares and trading
- Average volume
- 103.52K
- Shares outstanding
- 100.23M
- Float
- 25.96M
- Institutional ownership
- 15.6%
- Insider ownership
- 73.8%